Pharmakotherapie der Schizophrenie

Abstract

The management of schizophrenia patients remains one of the great challenges in psychiatry. Despite the undisputed effectiveness of antipsychotic drugs, patients and their physicians still face considerable difficulties mainly related to incomplete or lacking treatment response and the inability to predict the individual efficacy and tolerability. In this manuscript we review the key elements of pharmacological treatment of this disorder, encompassing acute and long-term management as well as specific management problems ranging from acutely violent patients to treatment-resistant subjects. Along with general treatment principles, the document provides specific information regarding efficacy and safety features of antipsychotics. Many of the currently available treatment recommendations/guidelines are based on the evidence reviewed here. This review is meant to serve as a guide for clinicians involved in managing schizophrenia, whether in a psychiatric hospital setting or as family physicians in private practice.

Psychoedukation

“…Dadurch ergab sich die Notwendigkeit, den Patienten und ihren Familien die Chancen zu verdeutlichen, die im Wandel von ursprünglich passiv-rezeptiven hin zu den heute aktiv-kreativen Therapiekonzepten liegen. Trotz der wissenschaftlich überzeugend belegten Wirksamkeit der Neuroleptika 23 24 25 und Antidepressiva inkl. Moodstabilizern 26 27 28 sträuben sich Patienten und oft auch deren Angehörige nach wie vor intuitiv gegen eine medikamentöse Behandlung.…”

Pharmakotherapie der juvenilen Schizophrenie mit atypischen Neuroleptika

“…Es kommt zu Störungen der/des: (17). Diep harmakotherapeutische Rezidivprophylaxe unterstützt auch Fortschritte während derRehabilitation (33).…”